Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae128 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Dushyant Singh Dahiya und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS, USA. Hauptthemen laut MEDLINE: Proctocolectomy, Restorative, Dilatation, Inflammatory Bowel Diseases, Colonic Pouches. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) is the treatment of choice for medically refractory inflammatory bowel disease (IBD). In this systematic review and meta-analysis, we assess outcomes and safety of endoscopic balloon dilatation (EBD) for IPAA strictures.
Methods
A systematic search of numerous databases was performed through June 2023 to identify studies reporting on the outcomes of EBD in pouch-related strictures. Outcomes included technical success, clinical success at index dilation and in pouch retention, recurrence of symptoms post-EBD, and adverse events of EBD. Meta-analysis was performed using a random-effects model, and results were expressed in terms of pooled rates along with relevant 95% confidence intervals (CIs). Heterogeneity was assessed using Cochran Q statistical test with I2 statistics.
Results
Seven studies with 504 patients were included. The pooled rate of technical success and clinical success of index dilatation was 98.9% (95% CI, 94.8-99.8%; I20%) and 30.2% (95% CI, 7.1-71%; I20%), respectively. The pooled rate of clinical success in pouch retention without the need for additional surgery was 81.4% (95% CI, 69.6-89.3%; I272%). The pooled failure rate of EBD was 18.6% (95% CI, 10.7-30.4%, I272%). The pooled rate of recurrence of symptoms after index dilatation was 58.9% (95% CI, 33.3-80.5%; I213%). The pooled rate of serious adverse events was 1.8% (95% CI, 1-3.5%, I20%). No deaths related to EBD were reported.
Conclusions
Endoscopic balloon dilatation is safe and highly effective for management of IPAA strictures. Additional studies are needed to compare its efficacy with surgical interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology & Motility, The University of Kansas School of Medicine, Kansas City, KS, USA.
- Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Gastroenterology, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
- Orlando Gastroenterology PA, Orlando, FL, USA.
- Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA.
- Gastroenterology Unit, Department of Biomedical Science, Foggia University Hospital, Foggia, Puglia, Italy.
ORCID-Profile: Dushyant Singh Dahiya, Saurabh Chandan, Gursimran S Kochhar
Zitieren
APA
Dahiya, D. S., Jena, A., Bapaye, J., Mohan, B. P., Kassab, L. L., Facciorusso, A., Chandan, S., & Kochhar, G. S. (2025). Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae128
Vancouver
Dahiya DS, Jena A, Bapaye J, Mohan BP, Kassab LL, Facciorusso A, et al. Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae128
BibTeX
@article{Dahiya2025,
author = {Dahiya, Dushyant Singh and Jena, Anuraag and Bapaye, Jay and Mohan, Babu P and Kassab, Lena L and Facciorusso, Antonio and Chandan, Saurabh and Kochhar, Gursimran S},
title = {Endoscopic Balloon Dilatation of Ileal Pouch-Anal Anastomosis Strictures in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae128}
}
EUVIMED